Development of Personalized Balanced Nutrition Concept Through an IT Platform
NCT ID: NCT05462444
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
450 participants
OBSERVATIONAL
2021-03-29
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic Disease
NCT05177744
Clinical and Immunological Evaluation of Children With Allergies
NCT00102570
Comparability and Standardization of Controlled Allergen Challenge Facilities
NCT02543346
Validation of an Allergic Rhinitis Control Test in Children
NCT03075917
Understanding the Immune System's Role in Tree Nut and Peanut Allergies: Key Biomarkers for Diagnosis and Treatment Monitoring and Treatment Targets
NCT06554691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. children who have a developed food allergy
2. children at risk of developing mild, moderate or severe allergic reaction to food
3. children with an allergological indication
The children with allergological indication (c) will be sent for further specialist evaluation, diagonstics and nutritionist advice at CHS.
The investigators will monitor how many kindergarten children have developed food allergy, food intolerance and another allergy (eg. inhalation allergy). Children with another type of allergy will be the refference control.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children with food allergy
Skin prick test
Skin prick test with a standard pallete of inhalational and nutritional allergens
Children with food intolerance
Skin prick test
Skin prick test with a standard pallete of inhalational and nutritional allergens
Children with other allergies (reference group)
Skin prick test
Skin prick test with a standard pallete of inhalational and nutritional allergens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Skin prick test
Skin prick test with a standard pallete of inhalational and nutritional allergens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children from 1 to 6 years old
Exclusion Criteria
* Neurological disorders that affect oral motorics
* Chronic gastrointestinal disorders
* Severe metabolic disorders
1 Year
6 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IN2 Ltd.
UNKNOWN
Children's Hospital Srebrnjak
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mirjana Turkalj, MD
Professor, MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital Srebrnjak
Zagreb, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KK.01.1.1.07.0074
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.